A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants

NCT06345755 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions

DRUG: VX-407
DRUG: Placebo
DRUG: Midazolam
DRUG: VX-407

Sponsor

Vertex Pharmaceuticals Incorporated